These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1059372)

  • 1. Biochemistry and biological effects of the pyrazofurins (pyrazomycins): initial clinical trial.
    Gutowski GE; Sweeney MJ; DeLong DC; Hamill RL; Gerzon K; Dyke RW
    Ann N Y Acad Sci; 1975 Aug; 255():544-51. PubMed ID: 1059372
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening data from the cancer chemotherapy National Service Center Screening Laboratories. XLV.
    Schepartz SA; Abbott BJ; Leiter J
    Cancer Res; 1967 Nov; 27(11 Pt 2):1115-283. PubMed ID: 4294535
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin.
    Barbieri B; Giuliani FC; Bordoni T; Casazza AM; Geroni C; Bellini O; Suarato A; Gioia B; Penco S; Arcamone F
    Cancer Res; 1987 Aug; 47(15):4001-6. PubMed ID: 3607745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of L-dopa, noradrenalin and adrenalin on P-388 mouse leukemia, B-16 mouse melanoma and E 0771 mammary carcinoma.
    Shohat B; Kott E; Bornstein B
    Experientia; 1975 Jan; 31(1):110-1. PubMed ID: 1112301
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXXIX. Plant extracts.
    Abbott BJ; Hartwell JL; Leiter J; Perdue RE; Price JR; Schepartz SA
    Cancer Res; 1967 Feb; 27(2 Pt 2):1-171. PubMed ID: 4289484
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
    Heyes J; Catherall EJ; Cockburn A
    Cancer Chemother Rep; 1973; 57(3):263-8. PubMed ID: 4751253
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyrimidine derivatives. 8. 5-Arylazopyrimidines and their inhibitory effects against transplantable mouse tumors.
    Israel M; Schlein HN; Maddock CL; Farber S; Modest EJ
    J Pharm Sci; 1966 Jun; 55(6):568-72. PubMed ID: 5924119
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].
    Maral R; Bourat G; Ducrot R; Fournel J; Ganter P; Julou L; Koenig F; Myon J; Pascal S; Pasquet J; Populaire P; de Ratuld Y; Werner GH
    Pathol Biol; 1967 Oct; 15(19):903-8. PubMed ID: 4296784
    [No Abstract]   [Full Text] [Related]  

  • 9. Some effects of adenosine 3',5'-monophosphate and double stranded RNA, poly I poly C, on Friend leukemia in mice.
    Gericke D; Chandra P; Wacker A
    Hoppe Seylers Z Physiol Chem; 1970 Mar; 351(3):411-2. PubMed ID: 5420715
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucan:inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models.
    Di Luzio NR; McNamee R; Browder WI; Williams D
    Cancer Treat Rep; 1978 Nov; 62(11):1857-66. PubMed ID: 728903
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of murine erythroleukemia cells to differentiate: a model for the detection of new anti-tumor drugs.
    Marks PA; Reuben R; Epner E; Breslow R; Cobb W; Bogden AE; Rifkind RA
    Antibiot Chemother (1971); 1978; 23():33-41. PubMed ID: 274100
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotoxin therapy: assessment by animal models.
    Griffin TW; Morgan AC; Blythman HE
    Cancer Treat Res; 1988; 37():433-55. PubMed ID: 2908638
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloid leukemia C-1498 as a screen for cancer chemotherapeutic agents.
    Bradner WT; Pindell MH
    Cancer Res; 1966 Apr; 26(4 Pt 2):375-90. PubMed ID: 4223140
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of synthetic double-stranded ribonucleic acid, poly I:C, on Friend leukemia in mice.
    Larson VM; Clark WR; Dagle GE; Hilleman MR
    Proc Soc Exp Biol Med; 1969 Nov; 132(2):602-7. PubMed ID: 5355112
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on mice of a tumor resistant strain (X-Gf). 8. Type C particles in mammary tumors of Friend leukemia virus-infected mice.
    Goldfeder A; de Harven E; Friend C
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):323-8. PubMed ID: 4327596
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors.
    Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM
    Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
    Mihich E; Gelzer J
    Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
    Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
    Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry. (II) (author's transl)].
    Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M; Suzuki I; Odashima S
    Eisei Shikenjo Hokoku; 1978; (96):91-4. PubMed ID: 750052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.